Skip to content
Search
T. Rowe Price Concentrated Global Equity Strategy

Conditions will change, the destination stays the same.

A global style-balanced, concentrated portfolio with a focus on high quality companies and supported by a world-class research engine.

View Products
  1. Approach
  2. Performance
  3. Ways to Invest
  4. Why T. Rowe Price
  5. Insights
Approach

Quality companies for changing conditions

The portfolio is built from the bottom-up, with a focus on strong businesses with durable competitive advantages across a wide range of companies. Constructing a style-balanced portfolio of companies including disruptors, steady growers, or cyclicals and turnarounds is how we believe we will be able to add value for clients over the long term, through changing market environments.

Cyclicals and turnarounds

Companies possessing a change catalyst and positioned at a favourable point of the cycle:

  • ConocoPhillips
  • Société Générale
Read More

Steady growth

Compounding growth companies in low volatile, less cyclical industries:

  • Taiwan Semiconductor Manufacturing Company
  • Amphenol
Read More

Disruptors

Earlier-stage, higher growth companies we believe are positioned on the right side of change:

  • AMD
  • Adyen
Read More

Portfolio Holdings are for illustrative purposes only, as of 31 December 2025. See Additional Information below.

Watch our video

Why consider Concentrated Global Equity Strategy 

Hear from our Portfolio Manager Peter Bates as he discusses his approach to managing a Concentrated Global Equity portfolio. Focusing on around 35 developed market stocks, Peter uses thorough research, careful risk management, and an emphasis on quality businesses to pursue differentiated results for clients.

View Transcript

Hello. I manage a global concentrated product focused on developed markets.

I think it's exciting because I'm focused on harnessing the 30 to 40 best ideas across our global research platform into a portfolio that can perform with no excuses.

I think it's unique because it's active management at its best, roughly 35 stocks.

I believe this is the right balance between getting the benefits of diversification without experiencing diversification from dilution of your best ideas.

Secondly, this product is very risk aware. I work very hard to manage tilts between factors like growth and value, as well as my siphuncle tilt so that I'm not betting on one macro variable. I believe that by betting on the performance of my 35 stocks, I can better control my outcomes.

Lastly, this means that for clients, either individuals or asset allocators, we would aim to get alpha that is truly uncorrelated to the market.

I achieve and build this portfolio by applying my process. Number 1, I focus on qualitatively owning good businesses that are getting better. Number 2, I need to value what I'm looking at and understand when I want to own it and when I want to sell it. I call this process the return matrix. Number 3, I need to understand how the stock or idea fits into the existing portfolio so that I avoid creating a macro or factor tilt.

I might find a really good idea, but if it's exactly like something else I already own in terms of the business it's in or the factor exposure it gives me, I need to make a tough decision between what I already own and the new idea.

By applying this consistent process, I believe I can generate strong performance with no excuses.

Value of AUD 10,000 invested since inception* in Global Select Equity Composite1

1 Global Select Equity is marketed in Australia as Concentrated Global Equity.

Past performance is no guarantee or a reliable indicator of future results.
* Since inception date: 31 December 2020.
Benchmark: MSCI World Index Net Index (see Additional Disclosures). Index returns shown with reinvestment of dividends after the deduction of withholding taxes.
Due to a short track record of T. Rowe Price Concentrated Global Equity Fund, the performance referenced is for the corresponding strategy's composite (i.e. Global Select Equity Composite). However, this information should not be an indication that the Fund would achieve similar results. Please see the GIPS® Composite Report for additional information on the composite.
This chart is for illustrative purposes only. Performance numbers quoted in AUD as of 31 December 2025 and are Gross of Fees. Gross performance returns are presented before management and all other fees, where applicable, but after trading expenses. Gross performance returns reflect the reinvestment of dividends and are net of all non-reclaimable withholding taxes on dividends, interest income, and capital gains. Returns shown would be lower when reduced by the advisory fees and any other expenses incurred in the management of an investment advisory account.
Valuations and performance are computed in U.S. dollars and converted to AUD. When converting U.S. dollar composite returns, benchmarks, dispersion, and/or asset data, the same exchange rate source is used consistently. Total returns in non-U.S. dollar currencies are calculated by adjusting U.S. dollar performance by the percent change in the U.S. dollar/foreign currency exchange rate (as determined by an independent third party) for the time periods stated.

Ways to invest

The T. Rowe Price Concentrated Global Equity Strategy is available as both a Fund and Separately Managed Account (SMA) depending on your individual client needs.

View Comparison

T. Rowe Price Concentrated Global Equity Fund (I Class)

APIR: ETL8650AU

Inception date 15 December 2021
Benchmark MSCI World ex-Australia Index Net (unhedged) 
No. of holdings 30 - 45 stocks
Management fee 0.85% pa2
Ratings

Lonsec: 4 - Recommended

Zenith: Recommended

View research house rating information

Fund literature
View Performance Report
View Fund Overview
View Fund Profile

 
Invest via platform

The T. Rowe Price Concentrated Global Equity Fund is available via Macquarie Wrap, CFS Edge, Netwealth, Hub24, BT Panorama and Powerwrap.

View Full Holdings Contact Us

Past performance is not a guarantee or a reliable indicator of future results.

The Management Fee for the T. Rowe Price Concentrated Global Equity Fund – I class is 0.85% p.a. and the Indirect Cost is 0.00% p.a.. Full details of other fees and charges are available within the Fund's Product Disclosure Statement and Reference Guide.

T. Rowe Price Concentrated Global Equity SMA

Inception date 24 March 2021
Benchmark MSCI World (ex-Australia) Index Net
No. of holdings 30 - 45 stocks
Ratings

Lonsec: 4 - Recommended

View research house rating information

Fund literature
View Quarterly Review
View SMA Performance Report
View SMA Overview View SMA Profile

 
Invest via platform

The T. Rowe Price Concentrated Global Equity SMA is available via Praemium SMA and CFS Edge.

View Full Holdings Contact Us

Past performance is not a guarantee or a reliable indicator of future results.

Why T. Rowe Price?

US$ 879B

Equity assets under management^

475+

Equity professionals

89+ Years

Equity experience
View Our Capabilities
We want to own durable and resilient companies with clear reasons why we expect them to continue to win in the future.
Peter J. Bates, CFA Peter J. Bates, CFA Portfolio Manager
avatar

Additional Information

Source. T. Rowe Price. 

Portfolio Holdings are for illustrative purposes only, as of 31 December 2025. See Additional Information below. 

The specific securities identified and described are for informational purposes only and do not represent recommendations or statement of opinion intended to influence a person or persons in making a decision in relation to investment. They do not represent the full portfolio. The specific securities identified and described do not represent all of the securities purchased, sold, or recommended for the portfolio, and no assumptions should be made that the securities identified and discussed were or will be profitable.

Additional Disclosures

All data as of 31 December 2025 unless otherwise stated.

^The total equity assets managed by T. Rowe Price Associates, Inc., and its investment advisory affiliates. Total equity assets include all equity separate accounts and funds along with a portion of certain T. Rowe Price U.S.-registered multi-asset funds as of 31 December 2025.

Source for MSCI data: MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.

Important Information

Available in Australia for Wholesale Clients only. Not for further distribution.

Equity Trustees Limited (“Equity Trustees”) (ABN: 46 004 031 298, AFSL: 240975), is the Responsible Entity for the T. Rowe Price Australian Unit Trusts ("the Fund").  Equity Trustees is a subsidiary of EQT Holdings Limited (ABN: 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).

This material has been prepared by T. Rowe Price Australia Limited ("TRPAU") (ABN: 13 620 668 895, AFSL: 503741) to provide you with general information only. In preparing this information, we did not take into account the investment objectives, financial situation or particular needs of any particular person. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Neither TRPAU, Equity Trustees nor any of its related parties, their employees or directors, provide any warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it.

Past performance is not a guarantee or a reliable indicator of future results. You should obtain a copy of the Product Disclosure Statement, which is available from Equity Trustees (www.eqt.com.au/insto) or TRPAU (www.troweprice.com.au), before making a decision about whether to invest in the Fund named in this material.

The Fund’s Target Market Determination is available here https://www.eqt.com.au/trprice. It describes who this financial product is likely to be appropriate for (i.e. the target market), and any conditions around how the product can be distributed to investors. It also describes the events or circumstances where the Target Market Determination for this financial product may need to be reviewed.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

202602-5223850